Loss of ileum decreases serum fibroblast growth factor 19 in relation to liver inflammation and fibrosis in pediatric onset intestinal failure

Journal of Hepatology

Volumn 62, Issue 6, 2015, Pages 1391-1397

  Mutanen, Annika ^a   Lohi, Jouko ^b   Heikkilä, Päivi ^b   Jalanko, Hannu ^a   Pakarinen, Mikko P ^a  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Bile acids; Interleukin 6; Liver disease; Parenteral nutrition; Tumor necrosis factor a

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILE ACID; BILIRUBIN; BILIRUBIN GLUCURONIDE; CHOLESTANOL; CHOLESTEROL; FIBROBLAST GROWTH FACTOR 19; GAMMA GLUTAMYLTRANSFERASE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; FGF19 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR; IL6 PROTEIN, HUMAN;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE ACID BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CHILD; CHILDHOOD DISEASE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CLINICAL EXAMINATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIGESTIVE TRACT PARAMETERS; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE BIOPSY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS; HUMAN; ILEUM DISEASE; ILEUM LOSS; INTESTINAL FAILURE; INTESTINAL FAILURE ASSOCIATED LIVER DISEASE; INTRAHEPATIC CHOLESTASIS; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARENTERAL NUTRITION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMALL BOWEL LENGTH; BIOSYNTHESIS; BLOOD; COMPLICATION; DEFICIENCY; ENTEROPATHY; ILEUM; INJURIES; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; PATHOLOGY; PRESCHOOL CHILD; SHORT BOWEL SYNDROME;

CHILD; CHILD, PRESCHOOL; CHOLESTEROL; FEMALE; FIBROBLAST GROWTH FACTORS; HEPATITIS; HUMANS; ILEUM; INTERLEUKIN-6; INTESTINAL DISEASES; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; MALE; PARENTERAL NUTRITION; SHORT BOWEL SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84929607468     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.01.004     Document Type: Article

References (48)

1. O. Goulet, F. Ruemmele, F. Lacaille, and V. Colomb Irreversible intestinal failure J Pediatr Gastroenterol Nutr 38 2004 250 269
2. B.A. Carter, and S.J. Karpen Intestinal failure-associated liver disease: management and treatment strategies past, present, and future Semin Liver Dis 27 2007 251 258
3. D.A. Kelly Intestinal failure-associated liver disease: what do we know today? Gastroenterology 130 2006 S70 S77
4. A. Mutanen, J. Lohi, P. Heikkilä, A. Koivusalo, R. Rintala, and M. Pakarinen Persistent abnormal liver fibrosis after weaning off parenteral nutrition in pediatric intestinal failure Hepatology 58 2013 729 738
5. K.C. El Kasmi, A.L. Anderson, M.W. Devereaux, S.A. Fillon, J.K. Harris, and M.A. Lovell Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury Hepatology 55 2012 1518 1528
6. K.C. El Kasmi, A.L. Anderson, M.W. Devereaux, P.M. Vue, W. Zhang, and K.D. Setchell Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease Sci Transl Med 5 2013 206ra137
7. P.M. Pereira-Fantini, S. Lapthorne, S.A. Joyce, N.L. Dellios, G. Wilson, and F. Fouhy Altered FXR signaling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease J Hepatol 61 2014 1115 1125
8. T. Matsubara, F. Li, and F.J. Gonzalez FXR signaling in the enterohepatic system Mol Cell Endocrinol 368 2013 17 29
9. J.H. Zhang, J.D. Nolan, S.L. Kennie, I.M. Johnston, T. Dew, and P.H. Dixon Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids Am J Physiol Gastrointest Liver Physiol 304 2013 G940 G948
10. J. Holt, G. Luo, A. Billin, J. Bisi, Y. McNeill, and K. Kozarsky Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis Genes Dev 17 2003 1581 1591
11. S. Kir, S. Kliewer, and D. Mangelsdorf Roles of FGF19 in liver metabolism Cold Spring Harb Symp Quant Biol 76 2011 139 144
12. M. Choi, A. Moschetta, A.L. Bookout, L. Peng, M. Umetani, and S.R. Holmstrom Identification of a hormonal basis for gallbladder filling Nat Med 12 2006 1253 1255
13. M. Lenicek, D. Duricova, V. Komarek, B. Gabrysova, M. Lukas, and Z. Smerhovsky Bile acid malabsorption in inflammatory bowel disease: assessment by serum markers Inflamm Bowel Dis 17 2011 1322 1327
14. A. Alisi, S. Ceccarelli, N. Panera, F. Prono, S. Petrini, and C. De Stefanis Association between serum atypical fibroblast growth factors 21 and 19 and pediatric nonalcoholic fatty liver disease PLoS One 26 2013 e67160
15. S. Modica, M. Petruzzelli, E. Bellafante, S. Murzilli, L. Salvatore, and N. Celli Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis Gastroenterology 142 2012 355 365 e1-e4
16. M.P. Pakarinen, A. Kurvinen, H. Gylling, T.A. Miettinen, M. Pesonen, and M. Kallio Cholesterol metabolism in pediatric short bowel syndrome after weaning off parenteral nutrition Dig Liver Dis 42 2010 554 559
17. A. Kurvinen, M.J. Nissinen, S. Andersson, P. Korhonen, T. Ruuska, and M. Taimisto Parenteral plant sterols and intestinal failure-associated liver disease in neonates J Pediatr Gastroenterol Nutr 54 2012 803 811
18. A. Mutanen, M.J. Nissinen, J. Lohi, P. Heikkilä, H. Gylling, and M.P. Pakarinen Serum plant sterols, cholestanol, and cholesterol precursors associate with histological liver injury in pediatric onset intestinal failure Am J Clin Nutr 100 2014 1085 1094
19. S. Beath, P. Davies, A. Papadopoulou, A. Khan, R. Buick, and J. Corkery Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors J Pediatr Surg 31 1996 604 606
20. S. Fitzgibbons, B. Jones, M. Hull, D. Zurakowski, D. Duro, and C. Duggan Relationship between biopsy-proven parenteral nutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome J Pediatr Surg 45 2010 95 99
21. M. Struijs, I. Diamond, N. de Silva, and P. Wales Establishing norms for intestinal length in children J Pediatr Surg 44 2009 933 938
22. A. Saari, U. Sankilampi, M. Hannila, V. Kiviniemi, K. Kesseli, and L. Dunkel New Finnish growth references for children and adolescents aged 0 to 20 years: length/height-for-age, weight-for-length/height, and body mass index-for-age Ann Med 43 2011 235 248
23. C. Wai, J. Greenson, R. Fontana, J. Kalbfleisch, J. Marrero, and H. Conjeevaram A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 2003 518 526
24. T.A. Miettinen Cholesterol metabolism during ketoconazole treatment in man J Lipid Res 29 1988 43
25. P. Bedossa, and T. Poynard An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group Hepatology 24 1996 289 293
26. I. Kim, S.H. Ahn, T. Inagaki, M. Choi, S. Ito, and G.L. Guo Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine J Lipid Res 48 2007 2664 2672
27. T. Inagaki, M. Choi, A. Moschetta, L. Peng, C.L. Cummins, and J.G. McDonald Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis Cell Metab 2 2005 217 225
28. S.J. Zweers, K.A. Booij, M. Komuta, T. Roskams, D.J. Gouma, and P.L. Jansen The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract Hepatology 55 2012 575 583
29. K.H. Song, T. Li, E. Owsley, S. Strom, and J.Y. Chiang Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression Hepatology 49 2009 297 305
30. T. Lundasen, C. Galman, B. Angelin, and M. Rudling Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man J Intern Med 260 2006 530 536
31. J. Walters, A. Tasleem, O. Omer, W. Brydon, T. Dew, and C. le Roux A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis Clin Gastroenterol Hepatol 7 2009 1189 1194
32. A. Beenken, and M. Mohammadi The FGF family: biology, pathophysiology and therapy Nat Rev Drug Discov 8 2009 235 253
33. S. Jones Mini-review: endocrine actions of fibroblast growth factor 19 Mol Pharm 5 2008 42 48
34. J. Luo, B. Ko, M. Elliott, M. Zhou, D. Lindhout, and V. Phung A nontumorigenic variant of FGF19 treats cholestatic liver diseases Sci Transl Med 30 2014 247ra100
35. F.G. Schaap, N.A. van der Gaag, D.J. Gouma, and P.L. Jansen High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis Hepatology 49 2009 1228 1235
36. T.C. Schreuder, H.A. Marsman, M. Lenicek, J.R. van Werven, A.J. Nederveen, and P.L. Jansen The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance Am J Physiol Gastrointest Liver Physiol 298 2010 G440 G445
37. H. Vlaardingerbroek, K. Ng, B. Stoll, N. Benight, S. Chacko, and L. Kluijtmans New generation lipid emulsions prevent PNALD in chronic parenterally fed preterm pigs J Lipid Res 55 2014 466 477
38. A.K. Jain, B. Stoll, D.G. Burrin, J.J. Holst, and D.D. Moore Enteral bile acid treatment improves parenteral nutrition-related liver disease and intestinal mucosal atrophy in neonatal pigs Am J Physiol Gastrointest Liver Physiol 302 2012 G218 G224
39. A. Kosters, and S.J. Karpen The role of inflammation in cholestasis: clinical and basic aspects Semin Liver Dis 30 2010 186 194
40. J.F. Whiting, R.M. Green, A.B. Rosenbluth, and J.L. Gollan Tumor necrosis factor-alpha decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis Hepatology 22 1995 1273 1278
41. I. Pappo, H. Bercovier, E. Berry, R. Gallilly, E. Feigin, and H.R. Freund Antitumor necrosis factor antibodies reduce hepatic steatosis during total parenteral nutrition and bowel rest in the rat JPEN J Parenter Enteral Nutr 19 1995 80 82
42. C.J. Aprahamian, M. Chen, Y. Yang, R.G. Lorenz, and C.M. Harmon Two-hit rat model of short bowel syndrome and sepsis: independent of total parenteral nutrition, short bowel syndrome is proinflammatory and injurious to the liver J Pediatr Surg 42 2007 992 997
43. A. El-Faramawy, L. El-Shazly, A. Abbass, and H. Ismail Serum IL-6 and IL-8 in infants with biliary atresia in comparison to intrahepatic cholestasis Trop Gastroenterol 32 2011 50 55
44. S. DeMauro, L. Kilpatrick, J. Gerdes, and S. Abbasi Early inflammatory markers for prediction of cholestasis in very-low-birth-weight infants Neonatology 102 2012 229 234
45. A.L. Buchman, A.A. Moukarzel, S. Bhuta, M. Belle, M.E. Ament, and C.D. Eckhert Parenteral nutrition is associated with intestinal morphologic and functional changes in humans JPEN J Parenter Enteral Nutr 19 1995 453 460
46. J. Tian, L. Hao, P. Chandra, D.P. Jones, I.R. Willams, and A.T. Gewirtz Dietary glutamine and oral antibiotics each improve indexes of gut barrier function in rat short bowel syndrome Am J Physiol Gastrointest Liver Physiol 296 2009 G348 G355
47. H. Yang, R. Finaly, and D.H. Teitelbaum Alteration in epithelial permeability and ion transport in a mouse model of total parenteral nutrition Crit Care Med 31 2003 1118 1125
48. B. Carter, O. Taylor, D. Prendergast, T. Zimmerman, R. Von Furstenberg, and D. Moore Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR Pediatr Res 62 2007 301 306